Mycozyl AL

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Mycozyl AL
Generic name: TOLNAFTATE
Manufacturer: PureTek Corporation
Product type: HUMAN OTC DRUG
SPL set ID: b82c9a8a-f6f1-dca6-e053-2995a90a47f9
SPL ID: 238464d1-700d-672b-e063-6394a90a4d49
Version: 3
Effective date: 2024-10-02
Source export date: 2026-10-30
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/772d0e4623a189b47f3ab71d7d51f9b3c89c5526f4cf3d218e1c921bb964b80c/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 18:26:46

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Mycozyl AL	openfda.brand_name
generic name		TOLNAFTATE	openfda.generic_name
manufacturer name		PureTek Corporation	openfda.manufacturer_name
ndc	package	59088-443-03	openfda.package_ndc
ndc	product	59088-443	openfda.product_ndc
ndc11	package	59088044303	derived:openfda.package_ndc
rxcui		313423	openfda.rxcui
spl id		238464d1-700d-672b-e063-6394a90a4d49	id
spl set id		b82c9a8a-f6f1-dca6-e053-2995a90a47f9	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use on children under 2 years of age unless directed by a doctor. When using this product ■ do not get into eyes Stop use and ask a doctor ■ for athlete's foot and ringworm - if irritation occurs or there is no improvement within 4 weeks ■ for prevention of athlete’s foot - if irritation occurs, discontinue use and consult a doctor Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.